Patents by Inventor Marie-France Poupon

Marie-France Poupon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination comprising a CDK inhibitor and a topoisomerase 1 inhibitor for the treatment of cancer and other proliferative diseases
    Publication number: 20060148828
    Abstract: A first aspect of the invention relates to a combination comprising a CDK inhibitor and CPT-11. A second aspect of the invention relates to a pharmaceutical product comprising a CDK inhibitor and CPT-11 as a combined preparation for simultaneous, sequential or separate use in therapy. A third aspect of the invention relates to a method of treating a proliferative disorder, said method comprising simultaneously, sequentially or separately administering a CDK inhibitor and CPT-11 to a subject.
    Type: Application
    Filed: December 9, 2005
    Publication date: July 6, 2006
    Applicant: Cyclacel Limited
    Inventors: Athos Gianella-Borradori, Marie-France Poupon
  • Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent
    Publication number: 20030166598
    Abstract: The invention concerns the use of Ro5-4864, and compounds derived therefrom, for preparing medicines for treating tumoral pathologies. The invention also concerns said compounds combined with an apoptosis-inducing agent, as combination products for simultaneous, separate or prolonged use, in cancer therapy.
    Type: Application
    Filed: April 8, 2003
    Publication date: September 4, 2003
    Inventors: Didier Decaudin, Guido Kroemer, Marie-France Poupon, Fariba Nemati, Arnaud Beurdeley-Thomas
  • Nutrient compositions deprived of methionine and supplemented with homocysteine
    Patent number: 5208039
    Abstract: Synthetic or semisynthetic nutrient composition intended to inhibit the development and the dissemination of malignant tumors in mammals, which composition is characterized in that it is deprived of methionine and supplemented with homocysteine; and utilization, in the preparation of such nutrient compositions, of a source of amino acids deprived of methionine.
    Type: Grant
    Filed: December 26, 1989
    Date of Patent: May 4, 1993
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Marie-France Poupon, Paule Echinard-Garin, Fabienne R. Breillout